Cargando…

A rare disease

Thrombocytopenia is a common finding in critically ill patients. Heparin-induced thrombocytopenia is an infrequent cause of a low platelet count. Intensivists should use the diagnostic classification system developed by the International Society on Thrombosis and Haemostasis to diagnose heparin-indu...

Descripción completa

Detalles Bibliográficos
Autor principal:	Wester, Jos PJ
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151898/ https://www.ncbi.nlm.nih.gov/pubmed/17224038 http://dx.doi.org/10.1186/cc5131

Ejemplares similares

Why rare disease needs precision medicine—and precision medicine needs rare disease
por: Might, Matthew, et al.
Publicado: (2022)

Observational studies: goldmines of information on rare diseases
por: Benjamin, Robert S.
Publicado: (2017)

Toward transcriptomics as a primary tool for rare disease investigation
por: Montgomery, Stephen B., et al.
Publicado: (2022)

Commentary: Descending necrotizing mediastinitis: Reclassifying a rare disease
por: Bajpai, Swara, et al.
Publicado: (2021)

The road to biosimilars in rare diseases ‐ ongoing lessons from Gaucher disease
por: Drelichman, Guillermo, et al.
Publicado: (2019)

Progressive multifocal leukoencephalopathy, a rare but devastating disease in AIDS patients
por: Falcó, Vicenç
Publicado: (2013)

Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal
por: Armeni, Patrizio, et al.
Publicado: (2021)

Monitoring clinical quality in rare disease services – experience in England
por: Kenny, Thomas D, et al.
Publicado: (2008)

Rethinking the nonprofit foundation: an emerging niche in the rare disease ecosystem
por: Bakker, Annette C, et al.
Publicado: (2017)

International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
por: Boycott, Kym M., et al.
Publicado: (2017)

Measuring health-related quality of life in patients with rare disease
por: Lenderking, William R., et al.
Publicado: (2021)

Commentary: Rare eye diseases: More than meets the eye!
por: Jayadev, Chaitra, et al.
Publicado: (2022)

Patients with rare diseases: from therapeutic orphans to pioneers of personalized treatments
por: Klein, Christoph, et al.
Publicado: (2017)

Rare disease informs mechanism and possible treatment of statin-associated myopathy
por: Harel, Tamar
Publicado: (2023)

Screening for mutations in human cardiomyopathy- is RBM24 a new but rare disease gene?
por: Gaertner, Anna, et al.
Publicado: (2018)

Commentary: Isolated unilateral absence of pulmonary artery, a rare disease with diverse presentations
por: Kim, Young Tae
Publicado: (2020)

The V-BRCH Project: building clinical trial research capacity for HIV and noncommunicable diseases in Nigeria
por: Aliyu, Muktar H., et al.
Publicado: (2021)

Rare Variants in Complement Genes May Not Be That Rare After All
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2023)

International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases
por: Boycott, Kym M, et al.
Publicado: (2019)

Cardiac amyloidosis and surgery: What do we know about rare diseases?
por: Mestres, Carlos A., et al.
Publicado: (2021)

Formulary Submissions: Value Claims, Protocols and Outcomes Based Contracting in Rare Disease
por: Langley, Paul C
Publicado: (2022)

Seminal analyses of HIV-1 transmission
por: Klasse, P.J.
Publicado: (2020)

Non-cognate ligands of Procrustean paratopes as potential vaccine components
por: Klasse, P.J.
Publicado: (2019)

Empowering rare disease patients through patient education: the new BehçeTalk programme
por: Marinello, D., et al.
Publicado: (2022)

HACE1 builds molecular crosstalks between rare diseases and (more) common disorders
por: Tort, Frederic
Publicado: (2022)

Improving Diagnostic Performance in Pediatrics: Three Steps Ahead
por: Olson, Andrew P.J.
Publicado: (2019)

The Early Treatment Phase in Parkinson’s Disease: Not a Honeymoon for All, Not a Honeymoon at All?
por: Alonso-Canovas, Araceli, et al.
Publicado: (2023)

Patient and family engagement in the development of core outcome sets for two rare chronic diseases in children
por: Vanderhout, Shelley M., et al.
Publicado: (2021)

Patient organization involvement and the challenge of securing access to treatments for rare diseases: report of a policy engagement workshop
por: Mikami, Koichi, et al.
Publicado: (2017)

The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview
por: Contesse, Marielle G., et al.
Publicado: (2019)

Shprintzen-Goldberg syndrome: a rare disorder
por: Yadav, Sankalp, et al.
Publicado: (2016)

Composite Pheochromocytoma: A Rare Form of Tumor
por: Lakshminarayana, G. R.
Publicado: (2019)

Perspective of α(v)β(6)-Integrin Imaging for Clinical Management of Pancreatic Carcinoma and Its Precursor Lesions
por: Steiger, Katja, et al.
Publicado: (2017)

Patient‐driven search for rare disease therapies: the Fondazione Telethon success story and the strategy leading to Strimvelis
por: Monaco, Lucia, et al.
Publicado: (2017)

The physician-scientists: rare species in Africa
por: Adefuye, Anthonio Oladele, et al.
Publicado: (2018)

Commentary: Navigating the path rarely taken
por: Lazar, John F.
Publicado: (2020)

Facebook Groups Can Provide Support for Patients with Rare Diseases and Reveal Truths About the Secret Lives of Patients
por: Gaddy, Anna, et al.
Publicado: (2021)

Generating evidence for diagnosis and therapy of RarE LIVEr disease: the RELIVE Initiative for systematic reviews and meta-analyses
por: Fuchs, Juri, et al.
Publicado: (2022)

Towards key scientific questions in the diagnosis and treatment of rare diseases: Summary from the 297th Meeting of the Shuangqing Forum
por: Zhu, Cai-Yun, et al.
Publicado: (2022)

Two rare pathologies of male urethra in children
por: Moralioğlu, Serdar
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0k6t7futdp0r3t76rjg3t1m6c5